Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Barcelona
Clinical trial register · Spain

Clinical Trials in Barcelona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5909 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:19 UTC
5909
Studies in scope
all four open statuses
3108
Recruiting now
open to new participants
1135
Lead sponsors
across recruiting studies
Top sites
Barcelona 18 Madrid 17 Málaga 7 Seville 7 Multiple Locations 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca189 Merck Sharp & Dohme LLC113 Novartis Pharmaceuticals106 Janssen Research & Development, LLC98 Hoffmann-La Roche83 Eli Lilly and Company83 Pfizer59 AbbVie58 GlaxoSmithKline57 Bristol-Myers Squibb57 Hospital Universitari Vall d'Hebron Research Institute48 Boehringer Ingelheim47 Sanofi46 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau39 Amgen39 Hospital Clinic of Barcelona37 Daiichi Sankyo32 Novo Nordisk A/S31 Gilead Sciences27 Regeneron Pharmaceuticals25 Incyte Corporation23 Fundacion Clinic per a la Recerca Biomédica22 Parc de Salut Mar21 European Organisation for Research and Treatment of Cancer - EORTC20 Genmab20 argenx20 Takeda19 Bayer18 Fundación EPIC17 BeOne Medicines16 BioNTech SE15 Fundación GECP15 Alexion Pharmaceuticals, Inc.14 Ipsen14 University of Barcelona14 Fundació Sant Joan de Déu13 Vall d'Hebron Institute of Oncology13 Seagen, a wholly owned subsidiary of Pfizer13 MedSIR13 PETHEMA Foundation12 Genentech, Inc.12 Celgene12 Abbott Medical Devices12 SOLTI Breast Cancer Research Group11 Exelixis11 Astellas Pharma Global Development, Inc.11 Taiho Oncology, Inc.10 Boston Scientific Corporation10 Ionis Pharmaceuticals, Inc.9 EMD Serono Research & Development Institute, Inc.9 Universitat Internacional de Catalunya9 UCB Biopharma SRL9 Barcelonabeta Brain Research Center, Pasqual Maragall Foundation9 ViiV Healthcare9 Alnylam Pharmaceuticals9 Institut de Recherches Internationales Servier8 ETOP IBCSG Partners Foundation7 Loxo Oncology, Inc.7 Biogen7 Revolution Medicines, Inc.7 Hospital Universitari de Bellvitge7 Swedish Orphan Biovitrum7 Mirum Pharmaceuticals, Inc.7 Consorci Sanitari de l'Alt Penedès i Garraf7 UNICANCER6 Pierre Fabre Medicament6 Mirati Therapeutics Inc.6 Jazz Pharmaceuticals6 University Medical Center Groningen6 Eisai Inc.6 University Ramon Llull6 Fundacion Dexeus6 Washington University School of Medicine6 Princess Maxima Center for Pediatric Oncology6 MedImmune LLC6 Gustave Roussy, Cancer Campus, Grand Paris6 Fundación Pública Andaluza para la gestión de la Investigación en Sevilla6 Consorcio Centro de Investigación Biomédica en Red (CIBER)5 Parc Sanitari Pere Virgili5 University Hospital, Basel, Switzerland5 Celldex Therapeutics5 Replimune, Inc.5 Vertex Pharmaceuticals Incorporated5 CatalYm GmbH5 Insel Gruppe AG, University Hospital Bern5 Tesaro, Inc.5 Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea5 Deciphera Pharmaceuticals, LLC5 Stichting Hemato-Oncologie voor Volwassenen Nederland5 Ultragenyx Pharmaceutical Inc5 Agios Pharmaceuticals, Inc.5 Immunocore Ltd5 Kite, A Gilead Company5 Autolus Limited5 Fundación para la Investigación del Hospital Clínico de Valencia5 Meyer Children's Hospital IRCCS5 BioInvent International AB5 H. Lundbeck A/S5 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company5 Aragon Pharmaceuticals, Inc.5 Sarepta Therapeutics, Inc.4 Stemline Therapeutics, Inc.4 RECORDATI GROUP4 Otsuka Pharmaceutical Development & Commercialization, Inc.4 Alkermes, Inc.4 Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina4 Consorci Sanitari de Terrassa4 Karuna Therapeutics, Inc., a Bristol Myers Squibb company4 Karyopharm Therapeutics Inc4 Philogen S.p.A.4 Alfasigma S.p.A.4 Centro Medico Teknon4 Medtronic Cardiovascular4 European Myeloma Network B.V.4 BicycleTx Limited4 Denali Therapeutics Inc.4 Facultat de ciencies de la Salut Universitat Ramon Llull4 Acerta Pharma BV4 Blueprint Medicines Corporation4 Instituto de Investigación Hospital Universitario La Paz4 Immunovant Sciences GmbH4 Fundacio Privada Mon Clinic Barcelona4 Grupo Espanol de Tumores Neuroendocrinos4 Fundación Española de Hematología y Hemoterapía4 Fundacio Puigvert4 CSL Behring4 ADARx Pharmaceuticals, Inc.4 iVascular S.L.U.4 Servier Bio-Innovation LLC4 Ascentage Pharma Group Inc.4 Cytokinetics4 Institut d'Investigació Biomèdica de Bellvitge4 Johnson & Johnson Enterprise Innovation Inc.4 W.L.Gore & Associates4 Eikon Therapeutics4 Azafaros B.V.3 Enliven Therapeutics3 Kura Oncology, Inc.3 Longboard Pharmaceuticals3 Weill Medical College of Cornell University3 Hospital Vall d'Hebron3 Dr. Inge Winter3 Instituto de Investigación Biomédica de Salamanca3 AOP Orphan Pharmaceuticals AG3 Arcus Biosciences, Inc.3 Vir Biotechnology, Inc.3 Copenhagen University Hospital, Rigshospitalet3 Celcuity Inc3 Teva Branded Pharmaceutical Products R&D LLC3 Alentis Therapeutics AG3 Xencor, Inc.3 Neurocrine Biosciences3 Entrada Therapeutics, Inc.3 Verastem, Inc.3 Population Health Research Institute3 Fundación Santiago Dexeus Font3 Medtronic3 Arrowhead Pharmaceuticals3 Société des Produits Nestlé (SPN)3 Relay Therapeutics, Inc.3 PharmaMar3 Vividion Therapeutics, Inc.3 ArriVent BioPharma, Inc.3 USWM CT, LLC3 Region Örebro County3 Grupo Espanol de Investigacion en Sarcomas3 Inhibrx Biosciences, Inc3 IFOM ETS - The AIRC Institute of Molecular Oncology3 ALX Oncology Inc.3 Avalyn Pharma Inc.3 Summit Therapeutics3 BioMarin Pharmaceutical3 Pyxis Oncology, Inc3 Syndax Pharmaceuticals3 Hospital del Mar3 EyeBiotech Ltd.3 Xenon Pharmaceuticals Inc.3 GBG Forschungs GmbH3 Janssen Pharmaceutica N.V., Belgium3 ITM Solucin GmbH3 International Extranodal Lymphoma Study Group (IELSG)3 Nuvalent Inc.3 Cogent Biosciences, Inc.3 City of Hope Medical Center3 Travere Therapeutics, Inc.3 Abivax S.A.3 iOnctura3 Shanghai Henlius Biotech3 Grupo Español Multidisciplinar de Melanoma3 Unity Health Toronto3 GRIN Therapeutics, Inc.2 Ellipses Pharma2 Biohaven Therapeutics Ltd.2 Biobizkaia Health Research Institute2 Zimmer Biomet2 Actelion2 Scholar Rock, Inc.2 Kartos Therapeutics, Inc.2 Merz Therapeutics GmbH2 AgNovos Healthcare, LLC2 Chugai Pharmaceutical2 NeuroDerm Ltd.2 The Lymphoma Academic Research Organisation2 Fundación Academia Española de Dermatología2 Aelis Farma2 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest2 TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)2 Byondis B.V.2 University of Oxford2 Biotronik SE & Co. KG2 University Hospital, Geneva2 Epygenix2 University College, London2 Joseph Broderick, MD2 Universitat Autonoma de Barcelona2 Alleviant Medical, Inc.2 Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD2 Ono Pharmaceutical Co., Ltd.2 AO Innovation Translation Center2 Chiesi Farmaceutici S.p.A.2 Mats Heyman2 Institut d'Investigacions Biomèdiques August Pi i Sunyer2 Basilea Pharmaceutica2 PTC Therapeutics2 Fecundis Lab SL2 Almirall, S.A.2 Artios Pharma Ltd2 IRCCS Azienda Ospedaliero-Universitaria di Bologna2 United Therapeutics2 Stichting European Myeloma Network2 Alliance Foundation Trials, LLC.2 Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal2 IRCCS San Raffaele2 University Rovira i Virgili2 JCR Pharmaceuticals Co., Ltd.2 Colorado Prevention Center2 Italfarmaco2 Oncomatryx Biopharma S.L.2 Procare Health Iberia S.L.2 Universitätsklinikum Hamburg-Eppendorf2 Akero Therapeutics, Inc2 AC Immune SA2 ORIC Pharmaceuticals2 Italian Sarcoma Group2 OrbusNeich2 mAbxience Research S.L.2 IDP Discovery Pharma S.L.2 Iovance Biotherapeutics, Inc.2 MediLink Therapeutics (Suzhou) Co., Ltd.2 Aesculap AG2 Grupo Español de Tratamiento de Tumores de Cabeza y Cuello2 UroGen Pharma Ltd.2 Dyne Therapeutics2 Medical University of Vienna2 Lacer S.A.2 AB Science2 Harmony Biosciences Management, Inc.2 University Health Network, Toronto2 FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS2 Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic2 Jesus Villar2 Prilenia2 Advanced Accelerator Applications2 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc2 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2 Asociación Española para el Estudio del Hígado2 Tyra Biosciences, Inc2 CoreAalst BV2 Institut National de la Santé Et de la Recherche Médicale, France2 Olema Oncology, Inc.2 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2 Servei Central d'Anestesiologia2 IO Biotech2 Pharvaris Netherlands B.V.2 University of Cologne2 Sumitomo Pharma America, Inc.2 NovoCure GmbH2 medac GmbH2 Vascutek Ltd.2 Nantes University Hospital2 Ryvu Therapeutics SA2 Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León2 Hansa Biopharma AB2 Gruppo Oncologico del Nord-Ovest2 Nelum Corp2 Fondazione Policlinico Universitario Agostino Gemelli IRCCS2 Kailera2 Dizal Pharmaceuticals2 Apellis Pharmaceuticals, Inc.2 Corcept Therapeutics2 Maastricht University Medical Center2 Istituto Giannina Gaslini2 Canadian Cancer Trials Group2 Mediar Therapeutics2 Aarhus University Hospital Skejby2 Alumis Inc2 P+F Products + Features GmbH2 Heidelberg University2 Inmunotek S.L.2 SystImmune Inc.2 Fundació Institut Germans Trias i Pujol2 Avidity Biosciences, Inc.2 Association for Innovation and Biomedical Research on Light and Image2 Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz2 Instituto de Investigación Marqués de Valdecilla2 UMC Utrecht2 European Foundation for Study of Chronic Liver Failure2 University of Southern California2 Astellas Pharma Inc2 Turning Point Therapeutics, Inc.2 PedAL BCU, LLC2 Ferring Pharmaceuticals2 Jiangsu HengRui Medicine Co., Ltd.2 Zai Lab (Shanghai) Co., Ltd.2 Orion Corporation, Orion Pharma2 Hospital del Mar Research Institute (IMIM)2 OncoVerity, Inc.2 Genzyme, a Sanofi Company2 Eva Bonfill2 Kardigan, Inc.2 Pharming Technologies B.V.2 Madrigal Pharmaceuticals, Inc.2 Institut Investigacio Sanitaria Pere Virgili2 Debiopharm International SA2 Corbus Pharmaceuticals Inc.2 ADC Therapeutics S.A.2 Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2 Puma Biotechnology, Inc.2 University Hospital, Montpellier2 Puerta de Hierro University Hospital2 Dianthus Therapeutics2 Crinetics Pharmaceuticals Inc.2 Anaconda Biomed S.L.2 University of Vic - Central University of Catalonia2 European Clinical Research Alliance for Infectious Diseases (ECRAID)2 Viatris Innovation GmbH2 Cullinan Therapeutics Inc.2 HistoSonics, Inc.2 Zymeworks BC Inc.2 European Association of Urology Research Foundation2 Zenas BioPharma (USA), LLC2 Kiniksa Pharmaceuticals International, plc2 Jules Bordet Institute1 Xcovery Holdings, Inc.1 MonTa Biosciences ApS1 BeiGene1 Womed1 PhenoNet, Inc.1 Calluna Pharma AS1 Maquet Cardiovascular1 Axon Therapies, Inc.1 Zogenix, Inc.1 Clarity Health Technologies, Inc1 NTC srl1 Biointelligent Technology Systems SL1 ImCheck Therapeutics, an Ipsen company1 Inotrem1 Children's Oncology Group1 Quetzal Therapeutics1 M.A. Med Alliance S.A.1 University of Zurich1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 35Pharma Inc., a GSK company1 Igenomix1 AtriCure, Inc.1 K36 Therapeutics, Inc.1 CellCentric Ltd.1 Medtronic MiniMed, Inc.1 Stanford University1 Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias1 Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 Instituto Oncológico Dr Rosell1 Noucor Health S.A.1 Hidde van der Ploeg1 Hellenic Institute for the Study of Sepsis1 NORCE Norwegian Research Centre AS1 University of Michigan1 SpliSense Ltd.1 Fundacion IMIM1 University of Mons1 Pharmazz, Inc.1 Arvinas Inc.1 Servier Affaires Médicales1 ParVation Therapeutics, Inc.1 Gyala Therapeutics1 Day One Biopharmaceuticals, Inc.1 University of Manitoba1 Advenchen Laboratories, LLC1 Duke Street Bio Ltd1 University Hospital, Grenoble1 Steba Biotech S.A.1 SymBio Pharmaceuticals1 Ascendis Pharma Oncology Division A/S1 Xeltis1 Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 PPM Services S.A.1 Hamilton Health Sciences Corporation1 Rezolute1 Nykode Therapeutics ASA1 COMPASS Pathways1 Hospital HM Nou Delfos1 Hospital General Universitario de Alicante1 Abalos Therapeutics GmbH1 Menarini Group1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Ophtec BV1 MiWEndo Solutions S.L.1 ONL Therapeutics1 Philipp Dutkowski1 Parnassia Groep1 Agenus Inc.1 Inventiva Pharma1 Peptomyc S.L.1 RTI Surgical1 Amicus Therapeutics1 Intra-Cellular Therapies, Inc.1 HiFiBiO Therapeutics1 BioLineRx, Ltd.1 King's College London1 University of Rochester1 Gabriel Riva1 Fundació ACE Institut Català de Neurociències Aplicades1 Shockwave Medical, Inc.1 Rob Surgical Systems S.L.1 Centre Besai1 Pliant Therapeutics, Inc.1 Ciliatech1 Philips Clinical & Medical Affairs Global1 Tharick Pascoal1 Aleksander Krag1 Fundación Canaria Instituto de Investigación Sanitaria de Canarias1 Samsung Bioepis Co., Ltd.1 Rovi Pharmaceuticals Laboratories1 Generate Biomedicines1 Guardant Health, Inc.1 Xynomic Pharmaceuticals, Inc.1 Grupo Espanol Multidisciplinario del Cancer Digestivo1 Elion Therapeutics, Inc.1 Ascendis Pharma A/S1 Noema Pharma AG1 Predictheon Medical, S.L.1 Olatec Therapeutics, Inc.1 Accession Therapeutics Limited1 OneChain Immunotherapeutics1 Resolution Therapeutics Limited1 Vaderis Therapeutics AG1 T3 Pharmaceuticals AG1 MediWound Ltd1 Universitaire Ziekenhuizen KU Leuven1 Orthofix Inc.1 Genespire Srl1 D3 Bio (Wuxi) Co., Ltd1 TransThera Sciences (Nanjing), Inc.1 Indiana University1 Astria Therapeutics, Inc.1 M.D. Anderson Cancer Center1 Assistance Publique - Hôpitaux de Paris1 Vecmedical Spain, S.L.1 Inhibikase Therapeutics1 Intensity Therapeutics, Inc.1 Outcomes'101 Fertiga, Belgium1 Immunome, Inc.1 Advanced NanoTherapies1 RayzeBio, Inc.1 AIRNA Corporation1 Hospital Clínico Universitario de Valladolid1 Myopowers Medical Technologies France SAS1 Boston Children's Hospital1 NewAmsterdam Pharma1 Tectonic Operating Company, Inc.1 ReSport Clinic1 McMaster University1 EDUARDO ALBENIZ1 SOTIO Biotech AG1 Renaissance Pharma Ltd.1 Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital1 AlgoTherapeutix1 European Institute of Oncology1 David Gallardo-Pujol1 Aura Biosciences1 Grupo Español de Investigación en Cáncer de Ovario1 MiMARK Diagnostics, S.L.1 Pharmanutra S.p.a.1 Forma Therapeutics, Inc.1 Fundació Universitària del Bages1 Transgene1 Medtronic Cardiac Ablation Solutions1 ABLE Human Motion S.L.1 CStone Pharmaceuticals1 Adcytherix SAS1 Fundació d'investigació Sanitària de les Illes Balears1 Fundación de Investigación Biomédica - Hospital Universitario de La Princesa1 Verici Dx1 Repertoire Immune Medicines1 Tenax Therapeutics, Inc.1 National Institute of Oncology, Hungary1 Biocodex1 Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Fundación Española de Medicina1 Pheon Therapeutics1 Edgewise Therapeutics, Inc.1 Hospital San Carlos, Madrid1 Vor Biopharma1 Integrative Research Laboratories AB1 CardioRenal Systems, Inc.1 PedNet Haemophilia Research Foundation1 Rocket Pharmaceuticals Inc.1 Vifor Fresenius Medical Care Renal Pharma1 i+Med S.Coop.1 CUTISS AG1 David Garcia Cinca1 Azienda Ospedaliero-Universitaria Careggi1 Tobias Feuchtinger1 Zydus Therapeutics Inc.1 German Heart Institute1 Escola Universitària d'Infermeria i Teràpia Ocupacional de Terrassa1 Somagenetix AG1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 NEAT ID Foundation1 LMU Klinikum1 Qurient Co., Ltd.1 invoX Pharma Limited1 Central Hospital, Nancy, France1 Mundipharma Research Limited1 Cerevance1 Acumen Pharmaceuticals1 Universitätsmedizin Mannheim1 Fundación Sociedad Española de Oncologia Médica1 Imagine Institute1 Crystalys Therapeutics1 Anthos Therapeutics, Inc.1 Atea Pharmaceuticals, Inc.1 Airway Therapeutics, Inc.1 Spur Therapeutics1 Jakob Stenman1 Germans Trias i Pujol Hospital1 Åslaug Helland1 The Cleveland Clinic1 Ichnos Sciences SA1 Annexon, Inc.1 Hospital Universitario Central de Asturias1 Teknimed1 Wandercraft1 Galaxy Therapeutics INC1 Balton Sp.zo.o.1 GLSMED Learning Health S.A.1 Arafarma Group, S.A.1 Vedanta Biosciences, Inc.1 Sunnybrook Health Sciences Centre1 SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 Fore Biotherapeutics1 iPremom1 diana garcia1 Elevar Therapeutics1 Janssen Biotech, Inc.1 Anthogyr1 Pharmacyclics Switzerland GmbH1 Paris Translational Research Center for Organ Transplantation1 Deepull Diagnostics S.L.1 Apogee Therapeutics, Inc.1 Fundacion Oncosur1 Philippe ROUSSELOT1 Fitoplancton Marino, S.L.1 Persei Vivarium1 Nuvation Bio Inc.1 Spanish Oncology Genito-Urinary Group1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 Greece 2021 Committee1 Tenaya Therapeutics1 Multiple Sclerosis Center of Catalonia1 Ottimo Pharma Limited1 Tango Therapeutics, Inc.1 Tectonic Therapeutic1 NEC Bio B.V1 Spanish Breast Cancer Research Group1 GCA (Eurosilicone)1 Acrotech Biopharma Inc.1 4C Medical Technologies, Inc.1 Tesai Care SL1 MaaT Pharma1 Cook Research Incorporated1 Terremoto Biosciences Inc.1 Spanish Lung Cancer Group1 Actuate Therapeutics Inc.1 Nimbus Wadjet, Inc.1 Noah Labs1 ADVANCED MARKER DISCOVERY S.L.1 Inari Medical1 Lakefront Biotherapeutics NV1 Biotest1 University of Utah1 Cartesian Therapeutics1 Redx Pharma Ltd1 Danone Global Research & Innovation Center1 NMD Pharma A/S1 Intellia Therapeutics1 Treeline Biosciences, Inc.1 Philipp Schuetz1 X4 Pharmaceuticals1 T.O.A.D. Oncology SA1 CytoSorbents, Inc1 Gruppo Italiano Malattie EMatologiche dell'Adulto1 Nobel Biocare1 Acrivon Therapeutics1 VisionCare, Inc.1 Incyte Biosciences International Sàrl1 Hospital de Sant Rafael1 Praxis Precision Medicines1 Mestag Therapeutics Limited1 Target PharmaSolutions, Inc.1 DualityBio Inc.1 Friedreich's Ataxia Research Alliance1 Grey Wolf Therapeutics1 CarThera1 Calico Life Sciences LLC1 AO Foundation, AO Spine1 OSE Immunotherapeutics1 Nurix Therapeutics, Inc.1 Newcastle University1 University of Malaga1 Enterome1 Priothera SAS1 University of Manchester1 Skin Tech Pharma Group S.L.U.1 University of Campania Luigi Vanvitelli1 Alliance for Clinical Trials in Oncology1 Xinnate AB1 Poitiers University Hospital1 National Cancer Institute (NCI)1 Dompé Farmaceutici S.p.A1 Upstream Bio Inc.1 MOMA Therapeutics1 Tanabe Pharma America, Inc.1 Institute of Cancer Research, United Kingdom1 Fundación para la investigación biomética Hospital Infantil Universitario Niño Jesús1 Maria Joyera Rodríguez1 Eidos Therapeutics, a BridgeBio company1 Eodyne Systems SL1 AFT Pharmaceuticals, Ltd.1 Arbor Research Collaborative for Health1 Medtronic Cardiac Surgery1 The European Forum for Research and Education in Allergy and Airway Diseases1 Xentria, Inc.1 CMR Surgical Ltd1 CanariaBio Inc.1 iECURE, Inc.1 Insmed Incorporated1 Elizabeth Kilbey1 Imbria Pharmaceuticals, Inc.1 Albireo, an Ipsen Company1 IRCCS Sacro Cuore Don Calabria di Negrar1 Cellectar Biosciences, Inc.1 iTeos Therapeutics1 Guerbet1 Quell Therapeutics Limited1 Occlutech International AB1 National University of Ireland, Galway, Ireland1 Prelude Therapeutics Incorporated1 Helena DOMINGUEZ1 Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia1 Beeline Medicines Corporation1 Centre hospitalier de l'Université de Montréal (CHUM)1 Boston University1 Camurus AB1 Reprieve Cardiovascular, Inc1 Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta1 University Hospital of Cologne1 University of Siena1 Oncoinvent Solutions AS1 Martin Huelsmann1 Bicara Therapeutics1 Maurizio Tonetti1 Montse Palacio1 Geron Corporation1 Johns Hopkins University1 Eagle Pharmaceuticals, Inc.1 ARCAGY/ GINECO GROUP1 Laboratoires Thea1 VarmX B.V.1 Prokrea BCN, S.L.1 Marengo Therapeutics, Inc.1 LeonaBio1 Partner Therapeutics, Inc.1 HotSpot Therapeutics, Inc1 Fidia Farmaceutici s.p.a.1 Bold Therapeutics, Inc.1 Apollomics Inc.1 Y-mAbs Therapeutics1 Mitra Bio1 CHDI Foundation, Inc.1 Corxel Pharmaceuticals1 ITB-Med LLC1 Dr. Yaroslav Winter1 Leukos Biotech S.L.1 AVEO Pharmaceuticals, Inc.1 Luis Eduardo Estévez Cachafeiro1 Felix Perez Tejera1 Elios Vision, Inc.1 Pedro Victor López Plaza1 Charite University, Berlin, Germany1 Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 WhiteSwell, Limited1 University of Milano Bicocca1 Michael J. Fox Foundation for Parkinson's Research1 National University of Singapore1 The University of Texas Health Science Center, Houston1 German CLL Study Group1 Francesc Colom, PsyD, PhD1 RyCarma Therapeutics, Inc.1 Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)1 Britannia Pharmaceuticals Ltd.1 Fondazione Ricerca Traslazionale1 Abbisko Therapeutics Co, Ltd1 European Breast Cancer Research Association of Surgical Trialists1 DR Healthcare - biotexia1 Gossamer Bio USA, Inc.1 Göteborg University1 Shanghai Golden Leaf MedTec Co. Ltd1 DGM Vascular1 Establishment Labs1 Anna Cruceta1 Exciva GmbH1 Akcea Therapeutics1 Miltenyi Biomedicine GmbH1 Change Accelerator in Respiratory Care1 Smith & Nephew, Inc.1 Australasian Gastro-Intestinal Trials Group1 Devintec Sagl1 Medicenna Therapeutics, Inc.1 Innovacell GmbH1 AskBio Inc1 Universidad Autonoma de Madrid1 Icahn School of Medicine at Mount Sinai1 Institut Claudius Regaud1 C4 Therapeutics, Inc.1 Janssen-Cilag Ltd.1 NS Pharma, Inc.1 Silence Therapeutics plc1 Epygon1 University of Cyprus1 Egle Therapeutics1 Greenwich LifeSciences, Inc.1 Francisco J. Blanco1 Grupo Español de Rehabilitación Multimodal1 Profound Medical Inc.1 Iria Grande1 Dentsply Sirona Implants and Consumables1 Breast Cancer Trials, Australia and New Zealand1 Prof. Valérie Mc Lin1 Humanitas Hospital, Italy1 Hospital General Universitario Gregorio Marañon1 Probelte Pharma S.L.U.1 University Hospital Muenster1 Centre Hospitalier Universitaire de Besancon1 DiaMedica Therapeutics Inc1 AusperBio Therapeutics Inc.1 Qilu Pharmaceutical Co., Ltd.1 Ultrasound-Innovation Medtech, S.L.1 Epizyme, Inc.1 OncoSil Medical Limited1 Adacyte Therapeutics SL1 Alterome Therapeutics, Inc.1 One-carbon Therapeutics AB1 eleva GmbH1 Orthofix s.r.l.1 Biocon Biologics UK PLC1 Swiss GO Trial Group1 University of Maryland, Baltimore1 Orphalan1 Savara Inc.1 OnKure, Inc.1 Kumquat Biosciences Inc.1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 ABX advanced biochemical compounds GmbH1 Inhatarget Therapeutics1 Advenchen Pharmaceuticals, LLC.1 Recornea Srl1 ReCor Medical, Inc.1 Rotkreuzklinikum München gGmbH1 Ad scientiam1 Checkpoint Therapeutics, Inc.1 Radboud University Medical Center1 CEBIOTEX1 Prostate Cancer Clinical Trials Consortium1 Gyroscope Therapeutics Limited1 ImmunoVaccine Technologies, Inc. (IMV Inc.)1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Biosensors Europe SA1 Bioprojet1 Crescent Biopharma, Inc.1 Medtronic Neurovascular Clinical Affairs1 Idoven 1903 S.L.1 Oriol Manuel1 AUSL Romagna Rimini1 Citryll BV1 GCP-Service International West GmbH1 Epics Therapeutics1 University of Leicester1 Eledon Pharmaceuticals1 Oruka Therapeutics, Inc.1 Grupo Español de Investigación en Neurooncología1 Gradient Denervation Technologies1 Science Corporation1 AviadoBio Ltd1 Biotronik AG1 Batea Oncology1 Medical University of Graz1 McGill University Health Centre/Research Institute of the McGill University Health Centre1 Immutep S.A.S.1 Applied Therapeutics, Inc.1 Jesús Manuel Nieves Alonso1 A Thousand Colibris, S.L1 Alba Roca1 RapidPulse, Inc1 Institut Català de Traumatologia i Medicina de l'Esport1 Viridian Therapeutics, Inc.1 European Society for Trauma and Emergency Surgery1 DBV Technologies1 Baxalta now part of Shire1 Infanta Leonor University Hospital1 Panbela Therapeutics, Inc.1 JRI Orthopaedics1 Reinier de Graaf Groep1 Interlinked AB1 Moleculin Biotech, Inc.1 Galderma R&D1 Annetine Gelijns1 Centro Nacional de Investigaciones Oncologicas CARLOS III1 Prothya Biosolutions1 Fundacio Clinic Barcelona1 World Medica USA, LLC1 Premium Fertility1 Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1 University of Deusto1 Neuron23 Inc.1 Skyhawk Therapeutics, Inc.1 Schrödinger, Inc.1 Federation Francophone de Cancerologie Digestive1 Stephanie Grasso1 St. Anna Kinderkrebsforschung1 Institut für Pharmakologie und Präventive Medizin1 MoonLake Immunotherapeutics AG1 University of Edinburgh1 Istituto Italiano di Tecnologia1 Rapamycin Holdings Inc.1 Weizmann Institute of Science1 Instituto Médico Tecnológico SL1 Memorial Sloan Kettering Cancer Center1 Zura Bio Inc1 Niguarda Hospital1 Stalicla SA1 MicroPort Orthopedics Inc.1 Ricard Mellado Artigas1 San Raffaele University1 Rigel Pharmaceuticals1 Dren Bio1 Prevail Therapeutics1 Fondazione Michelangelo1 Vastra Gotaland Region1 Curis, Inc.1 King's College Hospital NHS Trust1 4D Molecular Therapeutics1 Helena Vall Roqué1 Liquidia Technologies, Inc.1 Kyowa Kirin Pharmaceutical Development Ltd1 ARTIDIS AG1 Advesya SAS1 Orchestra BioMed, Inc1 AriBio Co., Ltd.1 Judit Pich1 Nordberg Medical AB1 Klus Pharma Inc.1 University of Birmingham1 German Cancer Research Center1 Erasca, Inc.1 Alligator Bioscience AB1 Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company1 Sanofi Pasteur, a Sanofi Company1 Industrial Farmacéutica Cantabria, S.A.1 Mayo Clinic1 Medtronic Spinal and Biologics1 JOTEC GmbH1 Synthekine1 Iambic Therapeutics, Inc1 Esteve Pharmaceuticals, S.A.1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 Aptose Biosciences Inc.1 University of Seville1 Wim Janssens1 V-Wave Ltd1 Elpida Therapeutics SPC1 Juan M Garcia-Gomez1 NEOS Surgery1 Exactech1 Kliniken Beelitz GmbH1 Nouscom SRL1 Uniquity One (UNI)1 University of Alberta1 Delcath Systems Inc.1 Dimerix Bioscience Pty Ltd1 Astellas Gene Therapies1 Shenzhen Lifevalve Medical Scientific Co., Ltd.1 Alejandro Cruz Utrilla1 Linkoeping University1 Oxford BioTherapeutics Ltd1 Merida Biosciences1 Terumo Europe N.V.1 Iperboreal Pharma Srl1 Highlight Therapeutics1 Stealth BioTherapeutics Inc.1 University Medical Center Nijmegen1 VahatiCor, Inc.1 Fundación para la Investigación Biosanitaria del Principado de Asturias1 Shanghai Junshi Bioscience Co., Ltd.1 LEO Pharma1 Milestone Pharmaceuticals Inc.1 Fundación IVI1 Joan Sabater-Riera1 IDRX, Inc., a wholly owned subsidiary of GSK, LLC1 Institut Català d'Oncologia1 Leiden University Medical Center1 pharmaand GmbH1 Sun Pharmaceutical Industries Limited1 Institut Catala de Retina1 ExThera Medical Corporation1 University of Bologna1 Societat Catalana de Medicina Familiar i Comunitària, Assoc. (CAMFiC)1 GELLC (Grupo Español de Leucemia Linfocítica Crónica)1 Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas1 Eclipse Medical Ltd.1 Cardiac Dimensions, Inc.1 Medtronic - MITG1 CRISPR Therapeutics AG1 GWT-TUD GmbH1 Connecta Therapeutics, S.L.1 Disc Medicine, Inc1 Glaukos Corporation1 Octapharma1 Ivy Brain Tumor Center1 CDR-Life AG1 PMV Pharmaceuticals, Inc1 Leica Microsystems (Schweiz) AG1 Rijnstate Hospital1 Diagram B.V.1 BioAegis Therapeutics Inc.1 ModernaTX, Inc.1 Satellos Bioscience, Inc.1 HUYABIO International, LLC.1 Protagonist Therapeutics, Inc.1 Salubris Biotherapeutics Inc1 Solstice Oncology, Inc.1 Totus Medicines1 SynOx Therapeutics Limited1 Ocus Innovation Ireland Limited1 4TEEN4 Pharmaceuticals GmbH1 enGene, Inc.1 Priovant Therapeutics, Inc.1 Women's Cancer Study Group GmbH1 SecuraBio1 Laminar Pharmaceuticals1 Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)1 Clear sponsor filter
Target enrolment
to

Trials with a site in Barcelona

18 of 5909 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Bayer
Phase 3
117
Madrid, Barcelona, Córdoba, Málaga, Seville
2026-06-01
Recruiting
Bayer
Phase 1
130
Barcelona, Madrid
2026-04-07
Active, closed
Bayer
Phase 2
60
Barcelona, Alcázar de San Juan, Madrid, Seville
2025-11-19
Recruiting
Bayer
Phase 3
111
Esplugues de Llobregat, Córdoba, Madrid, Málaga, Seville, Barcelona
2025-11-19
Recruiting
Bayer
Phase 1/2
450
Barcelona, Pamplona, Logroño, Madrid, Pozuelo de Alarcón, Málaga, Valencia
2025-03-21
Recruiting
Bayer
Phase 1
148
Barcelona, Madrid, Pamplona
2025-02-28
Recruiting
Bayer
Phase 1
104
Barcelona
2024-11-08
Active, closed
Bayer
Phase 3
985
Santiago de Compostela, Santander, Barcelona, Cadiz, Madrid, Málaga, Murcia, Seville
2023-04-03
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Santiago de Compostela, Aravaca, Barcelona, Granada, Madrid, Seville, Valencia
2022-10-14
Recruiting
Bayer
Phase 1/2
430
L'Hospitalet de Llobregat, Barcelona, Madrid, Málaga, Valencia
2021-10-25
Active, closed
Bayer
Phase 3
774
Elche, Manacor, Palma de Mallorca, L'Hospitalet de Llobregat, Sabadell, Barcelona, Alcorcón, Cáceres
2020-10-20
Active, closed
Bayer
Phase 1/2
154
Barcelona
2015-12-16
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-spain/city/barcelona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,909 studies in total at the last sync on 17 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Barcelona that also match the filters currently applied.

How many clinical trials are recruiting in Barcelona?

10 of the 18 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Barcelona), 18 studies
PhaseStudiesRecruitingShare
Phase 38444.4%
Phase 15327.8%
Phase 1/23216.7%
Phase 22111.1%

Most active sponsors

Lead sponsors with the most studies (Barcelona)
Lead sponsorStudiesRecruiting
Bayer1810
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.